[JO-02] Oral Presentation 02

[JO-007] Baseline results in RESPOND: nusinersen in children with SMA who received onasemnogene abeparvovec

Taihei Homma¹、John Brandsema²、Julie Parsons³、Crystal Proud⁴、Richard Finkel⁵、Kathryn Swoboda⁶、Riccardo Masson⁷、Yingying Liu⁸、Corinne Makepeace⁸、Angela Paradis⁸、Zdenek Berger⁸、Joanne Wagner⁸、Kathleen Someramolina⁸ (1. Biogen Japan、 Tokyo、 Japan、2. Children's Hospital of Philadelphia、 Philadelphia、 PA、 USA、3. Children's Hospital Colorado、 Aurora、 CO、 USA、4. Children's Hospital of The King's Daughters、 Norfolk、 VA、 USA、5. Center for Experimental Neurotherapeutics、 St. Jude Children's Research Hospital、 Memphis、 TN、 USA、6. Massachusetts General Hospital、 Boston、 MA、 USA、7. Fondazione IRCCS Istituto Neurologico Carlo Besta、 Milan、 Italy、8. Biogen、 Cambridge、 MA、 USA)